nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—Tongue coated—Varenicline—nicotine dependence	0.0689	0.0884	CcSEcCtD
Oxybutynin—Hoarseness—Varenicline—nicotine dependence	0.0212	0.0272	CcSEcCtD
Oxybutynin—Sinus congestion—Varenicline—nicotine dependence	0.0188	0.024	CcSEcCtD
Oxybutynin—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0138	0.0177	CcSEcCtD
Oxybutynin—Paranoia—Varenicline—nicotine dependence	0.0137	0.0176	CcSEcCtD
Oxybutynin—Laryngeal pain—Varenicline—nicotine dependence	0.0137	0.0176	CcSEcCtD
Oxybutynin—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0127	0.0577	CbGpPWpGaD
Oxybutynin—Fungal infection—Varenicline—nicotine dependence	0.0121	0.0155	CcSEcCtD
Oxybutynin—Mydriasis—Varenicline—nicotine dependence	0.0117	0.015	CcSEcCtD
Oxybutynin—Dysphonia—Varenicline—nicotine dependence	0.0113	0.0145	CcSEcCtD
Oxybutynin—Eye irritation—Varenicline—nicotine dependence	0.0109	0.014	CcSEcCtD
Oxybutynin—Chest discomfort—Varenicline—nicotine dependence	0.0105	0.0135	CcSEcCtD
Oxybutynin—Accidental injury—Varenicline—nicotine dependence	0.0105	0.0135	CcSEcCtD
Oxybutynin—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0104	0.0474	CbGpPWpGaD
Oxybutynin—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0103	0.0132	CcSEcCtD
Oxybutynin—Thinking abnormal—Varenicline—nicotine dependence	0.0102	0.0131	CcSEcCtD
Oxybutynin—Nocturia—Varenicline—nicotine dependence	0.0101	0.0129	CcSEcCtD
Oxybutynin—Blood pressure increased—Varenicline—nicotine dependence	0.00933	0.012	CcSEcCtD
Oxybutynin—Eructation—Varenicline—nicotine dependence	0.00917	0.0118	CcSEcCtD
Oxybutynin—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0091	0.0413	CbGpPWpGaD
Oxybutynin—Salivary hypersecretion—Varenicline—nicotine dependence	0.00906	0.0116	CcSEcCtD
Oxybutynin—Nightmare—Varenicline—nicotine dependence	0.00901	0.0116	CcSEcCtD
Oxybutynin—Dry eye—Varenicline—nicotine dependence	0.00862	0.0111	CcSEcCtD
Oxybutynin—Oesophagitis—Varenicline—nicotine dependence	0.00853	0.0109	CcSEcCtD
Oxybutynin—Mouth ulceration—Varenicline—nicotine dependence	0.00844	0.0108	CcSEcCtD
Oxybutynin—Hypertonia—Varenicline—nicotine dependence	0.00818	0.0105	CcSEcCtD
Oxybutynin—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00814	0.037	CbGpPWpGaD
Oxybutynin—Mental disability—Varenicline—nicotine dependence	0.0081	0.0104	CcSEcCtD
Oxybutynin—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00788	0.0358	CbGpPWpGaD
Oxybutynin—Sleep disorder—Varenicline—nicotine dependence	0.00782	0.01	CcSEcCtD
Oxybutynin—Eye pain—Varenicline—nicotine dependence	0.0075	0.00962	CcSEcCtD
Oxybutynin—Injury—Varenicline—nicotine dependence	0.00737	0.00945	CcSEcCtD
Oxybutynin—Libido decreased—Varenicline—nicotine dependence	0.0073	0.00937	CcSEcCtD
Oxybutynin—Hot flush—Varenicline—nicotine dependence	0.00724	0.00928	CcSEcCtD
Oxybutynin—Increased appetite—Varenicline—nicotine dependence	0.00721	0.00924	CcSEcCtD
Oxybutynin—Amnesia—Varenicline—nicotine dependence	0.00721	0.00924	CcSEcCtD
Oxybutynin—Menopausal symptoms—Varenicline—nicotine dependence	0.00718	0.0092	CcSEcCtD
Oxybutynin—Thirst—Varenicline—nicotine dependence	0.00712	0.00913	CcSEcCtD
Oxybutynin—Arthritis—Varenicline—nicotine dependence	0.00697	0.00894	CcSEcCtD
Oxybutynin—Osteoarthritis—Varenicline—nicotine dependence	0.00677	0.00869	CcSEcCtD
Oxybutynin—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00672	0.00862	CcSEcCtD
Oxybutynin—Affect lability—Varenicline—nicotine dependence	0.00667	0.00855	CcSEcCtD
Oxybutynin—Migraine—Varenicline—nicotine dependence	0.00667	0.00855	CcSEcCtD
Oxybutynin—Psychotic disorder—Varenicline—nicotine dependence	0.00661	0.00848	CcSEcCtD
Oxybutynin—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00647	0.0294	CbGpPWpGaD
Oxybutynin—Urinary retention—Varenicline—nicotine dependence	0.00644	0.00826	CcSEcCtD
Oxybutynin—Mood swings—Varenicline—nicotine dependence	0.00642	0.00823	CcSEcCtD
Oxybutynin—Liver function test abnormal—Varenicline—nicotine dependence	0.00625	0.00802	CcSEcCtD
Oxybutynin—Dry skin—Varenicline—nicotine dependence	0.00621	0.00796	CcSEcCtD
Oxybutynin—Abdominal pain upper—Varenicline—nicotine dependence	0.00619	0.00793	CcSEcCtD
Oxybutynin—Breast disorder—Varenicline—nicotine dependence	0.00612	0.00785	CcSEcCtD
Oxybutynin—Nasopharyngitis—Varenicline—nicotine dependence	0.00606	0.00777	CcSEcCtD
Oxybutynin—Abdominal distension—Varenicline—nicotine dependence	0.00589	0.00756	CcSEcCtD
Oxybutynin—Asthma—Varenicline—nicotine dependence	0.00585	0.00751	CcSEcCtD
Oxybutynin—Dysphagia—Varenicline—nicotine dependence	0.00585	0.00751	CcSEcCtD
Oxybutynin—Bronchitis—Varenicline—nicotine dependence	0.00563	0.00722	CcSEcCtD
Oxybutynin—Abdominal discomfort—Varenicline—nicotine dependence	0.00561	0.0072	CcSEcCtD
Oxybutynin—Pollakiuria—Varenicline—nicotine dependence	0.00541	0.00693	CcSEcCtD
Oxybutynin—Erectile dysfunction—Varenicline—nicotine dependence	0.00539	0.00691	CcSEcCtD
Oxybutynin—Infestation—Varenicline—nicotine dependence	0.00522	0.00669	CcSEcCtD
Oxybutynin—Infestation NOS—Varenicline—nicotine dependence	0.00522	0.00669	CcSEcCtD
Oxybutynin—Depression—Varenicline—nicotine dependence	0.0052	0.00667	CcSEcCtD
Oxybutynin—Stomatitis—Varenicline—nicotine dependence	0.00509	0.00652	CcSEcCtD
Oxybutynin—Conjunctivitis—Varenicline—nicotine dependence	0.00507	0.00651	CcSEcCtD
Oxybutynin—Epistaxis—Varenicline—nicotine dependence	0.00492	0.00631	CcSEcCtD
Oxybutynin—Sinusitis—Varenicline—nicotine dependence	0.0049	0.00628	CcSEcCtD
Oxybutynin—CHRM5—Monoamine GPCRs—DRD2—nicotine dependence	0.00488	0.0222	CbGpPWpGaD
Oxybutynin—Hallucination—Varenicline—nicotine dependence	0.00466	0.00598	CcSEcCtD
Oxybutynin—Hypoaesthesia—Varenicline—nicotine dependence	0.00466	0.00598	CcSEcCtD
Oxybutynin—Urinary tract disorder—Varenicline—nicotine dependence	0.00463	0.00593	CcSEcCtD
Oxybutynin—Oedema peripheral—Varenicline—nicotine dependence	0.00462	0.00592	CcSEcCtD
Oxybutynin—Connective tissue disorder—Varenicline—nicotine dependence	0.0046	0.0059	CcSEcCtD
Oxybutynin—Urethral disorder—Varenicline—nicotine dependence	0.00459	0.00589	CcSEcCtD
Oxybutynin—Visual impairment—Varenicline—nicotine dependence	0.00452	0.00579	CcSEcCtD
Oxybutynin—Eye disorder—Varenicline—nicotine dependence	0.00438	0.00562	CcSEcCtD
Oxybutynin—Tinnitus—Varenicline—nicotine dependence	0.00437	0.0056	CcSEcCtD
Oxybutynin—Cardiac disorder—Varenicline—nicotine dependence	0.00435	0.00558	CcSEcCtD
Oxybutynin—Angiopathy—Varenicline—nicotine dependence	0.00425	0.00545	CcSEcCtD
Oxybutynin—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00423	0.0192	CbGpPWpGaD
Oxybutynin—Mediastinal disorder—Varenicline—nicotine dependence	0.00422	0.00542	CcSEcCtD
Oxybutynin—Arrhythmia—Varenicline—nicotine dependence	0.00419	0.00537	CcSEcCtD
Oxybutynin—CHRM5—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00411	0.0186	CbGpPWpGaD
Oxybutynin—Mental disorder—Varenicline—nicotine dependence	0.0041	0.00526	CcSEcCtD
Oxybutynin—Erythema—Varenicline—nicotine dependence	0.00408	0.00523	CcSEcCtD
Oxybutynin—Malnutrition—Varenicline—nicotine dependence	0.00408	0.00523	CcSEcCtD
Oxybutynin—Flatulence—Varenicline—nicotine dependence	0.00402	0.00515	CcSEcCtD
Oxybutynin—Dysgeusia—Varenicline—nicotine dependence	0.00399	0.00512	CcSEcCtD
Oxybutynin—Back pain—Varenicline—nicotine dependence	0.00395	0.00506	CcSEcCtD
Oxybutynin—Vision blurred—Varenicline—nicotine dependence	0.00384	0.00493	CcSEcCtD
Oxybutynin—Ill-defined disorder—Varenicline—nicotine dependence	0.00378	0.00485	CcSEcCtD
Oxybutynin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00378	0.0172	CbGpPWpGaD
Oxybutynin—CHRM5—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00377	0.0171	CbGpPWpGaD
Oxybutynin—Agitation—Varenicline—nicotine dependence	0.00375	0.00481	CcSEcCtD
Oxybutynin—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00373	0.0169	CbGpPWpGaD
Oxybutynin—Angioedema—Varenicline—nicotine dependence	0.00373	0.00478	CcSEcCtD
Oxybutynin—Malaise—Varenicline—nicotine dependence	0.00368	0.00472	CcSEcCtD
Oxybutynin—Syncope—Varenicline—nicotine dependence	0.00366	0.00469	CcSEcCtD
Oxybutynin—Palpitations—Varenicline—nicotine dependence	0.0036	0.00462	CcSEcCtD
Oxybutynin—Loss of consciousness—Varenicline—nicotine dependence	0.00358	0.0046	CcSEcCtD
Oxybutynin—Cough—Varenicline—nicotine dependence	0.00356	0.00456	CcSEcCtD
Oxybutynin—Convulsion—Varenicline—nicotine dependence	0.00353	0.00453	CcSEcCtD
Oxybutynin—Hypertension—Varenicline—nicotine dependence	0.00352	0.00452	CcSEcCtD
Oxybutynin—Chest pain—Varenicline—nicotine dependence	0.00347	0.00445	CcSEcCtD
Oxybutynin—Arthralgia—Varenicline—nicotine dependence	0.00347	0.00445	CcSEcCtD
Oxybutynin—Anxiety—Varenicline—nicotine dependence	0.00346	0.00444	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00345	0.00442	CcSEcCtD
Oxybutynin—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00344	0.0156	CbGpPWpGaD
Oxybutynin—Discomfort—Varenicline—nicotine dependence	0.00343	0.0044	CcSEcCtD
Oxybutynin—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.00343	0.0156	CbGpPWpGaD
Oxybutynin—Dry mouth—Varenicline—nicotine dependence	0.0034	0.00435	CcSEcCtD
Oxybutynin—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.0034	0.0154	CbGpPWpGaD
Oxybutynin—Oedema—Varenicline—nicotine dependence	0.00333	0.00427	CcSEcCtD
Oxybutynin—Infection—Varenicline—nicotine dependence	0.00331	0.00424	CcSEcCtD
Oxybutynin—Shock—Varenicline—nicotine dependence	0.00328	0.0042	CcSEcCtD
Oxybutynin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00327	0.0149	CbGpPWpGaD
Oxybutynin—Nervous system disorder—Varenicline—nicotine dependence	0.00326	0.00419	CcSEcCtD
Oxybutynin—Tachycardia—Varenicline—nicotine dependence	0.00325	0.00417	CcSEcCtD
Oxybutynin—Skin disorder—Varenicline—nicotine dependence	0.00323	0.00415	CcSEcCtD
Oxybutynin—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00323	0.0147	CbGpPWpGaD
Oxybutynin—Anorexia—Varenicline—nicotine dependence	0.00317	0.00407	CcSEcCtD
Oxybutynin—Hypotension—Varenicline—nicotine dependence	0.00311	0.00399	CcSEcCtD
Oxybutynin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00306	0.0139	CbGpPWpGaD
Oxybutynin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00303	0.00389	CcSEcCtD
Oxybutynin—Insomnia—Varenicline—nicotine dependence	0.00301	0.00386	CcSEcCtD
Oxybutynin—Somnolence—Varenicline—nicotine dependence	0.00296	0.00379	CcSEcCtD
Oxybutynin—Dyspepsia—Varenicline—nicotine dependence	0.00293	0.00376	CcSEcCtD
Oxybutynin—Decreased appetite—Varenicline—nicotine dependence	0.00289	0.00371	CcSEcCtD
Oxybutynin—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00289	0.0131	CbGpPWpGaD
Oxybutynin—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00288	0.0131	CbGpPWpGaD
Oxybutynin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00287	0.00369	CcSEcCtD
Oxybutynin—Fatigue—Varenicline—nicotine dependence	0.00287	0.00368	CcSEcCtD
Oxybutynin—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00285	0.013	CbGpPWpGaD
Oxybutynin—Constipation—Varenicline—nicotine dependence	0.00285	0.00365	CcSEcCtD
Oxybutynin—Pain—Varenicline—nicotine dependence	0.00285	0.00365	CcSEcCtD
Oxybutynin—Feeling abnormal—Varenicline—nicotine dependence	0.00274	0.00352	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Varenicline—nicotine dependence	0.00272	0.00349	CcSEcCtD
Oxybutynin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00269	0.0122	CbGpPWpGaD
Oxybutynin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00265	0.012	CbGpPWpGaD
Oxybutynin—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00265	0.012	CbGpPWpGaD
Oxybutynin—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00265	0.012	CbGpPWpGaD
Oxybutynin—Urticaria—Varenicline—nicotine dependence	0.00264	0.00339	CcSEcCtD
Oxybutynin—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00264	0.012	CbGpPWpGaD
Oxybutynin—Abdominal pain—Varenicline—nicotine dependence	0.00263	0.00337	CcSEcCtD
Oxybutynin—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00262	0.0119	CbGpPWpGaD
Oxybutynin—Hypersensitivity—Varenicline—nicotine dependence	0.00245	0.00315	CcSEcCtD
Oxybutynin—Asthenia—Varenicline—nicotine dependence	0.00239	0.00306	CcSEcCtD
Oxybutynin—Pruritus—Varenicline—nicotine dependence	0.00236	0.00302	CcSEcCtD
Oxybutynin—CHRM5—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00234	0.0106	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00232	0.0105	CbGpPWpGaD
Oxybutynin—Diarrhoea—Varenicline—nicotine dependence	0.00228	0.00292	CcSEcCtD
Oxybutynin—CHRM5—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00225	0.0102	CbGpPWpGaD
Oxybutynin—Dizziness—Varenicline—nicotine dependence	0.0022	0.00282	CcSEcCtD
Oxybutynin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00218	0.00989	CbGpPWpGaD
Oxybutynin—Vomiting—Varenicline—nicotine dependence	0.00212	0.00271	CcSEcCtD
Oxybutynin—Rash—Varenicline—nicotine dependence	0.0021	0.00269	CcSEcCtD
Oxybutynin—Dermatitis—Varenicline—nicotine dependence	0.0021	0.00269	CcSEcCtD
Oxybutynin—Headache—Varenicline—nicotine dependence	0.00209	0.00267	CcSEcCtD
Oxybutynin—CHRM5—GPCR ligand binding—TAS2R16—nicotine dependence	0.00202	0.00917	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00199	0.00902	CbGpPWpGaD
Oxybutynin—Nausea—Varenicline—nicotine dependence	0.00198	0.00254	CcSEcCtD
Oxybutynin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00176	0.00798	CbGpPWpGaD
Oxybutynin—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00173	0.00787	CbGpPWpGaD
Oxybutynin—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00173	0.00784	CbGpPWpGaD
Oxybutynin—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00165	0.00749	CbGpPWpGaD
Oxybutynin—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00164	0.00747	CbGpPWpGaD
Oxybutynin—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00163	0.0074	CbGpPWpGaD
Oxybutynin—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00163	0.00739	CbGpPWpGaD
Oxybutynin—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0016	0.00729	CbGpPWpGaD
Oxybutynin—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00158	0.00719	CbGpPWpGaD
Oxybutynin—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00158	0.00716	CbGpPWpGaD
Oxybutynin—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00156	0.00709	CbGpPWpGaD
Oxybutynin—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0015	0.00679	CbGpPWpGaD
Oxybutynin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00142	0.00647	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00142	0.00645	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00142	0.00643	CbGpPWpGaD
Oxybutynin—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00141	0.0064	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.0014	0.00637	CbGpPWpGaD
Oxybutynin—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00139	0.00631	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00133	0.00602	CbGpPWpGaD
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0013	0.00592	CbGpPWpGaD
Oxybutynin—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00123	0.00557	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.0012	0.00547	CbGpPWpGaD
Oxybutynin—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00116	0.00525	CbGpPWpGaD
Oxybutynin—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00114	0.00518	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00114	0.00518	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00112	0.00507	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.0011	0.00498	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—TAS2R16—nicotine dependence	0.00104	0.0047	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000977	0.00444	CbGpPWpGaD
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000943	0.00428	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000918	0.00417	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000915	0.00416	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000906	0.00412	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—FGD1—nicotine dependence	0.000895	0.00406	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—OPRM1—nicotine dependence	0.000851	0.00386	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—FGD1—nicotine dependence	0.000813	0.00369	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.00081	0.00368	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000808	0.00367	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000803	0.00365	CbGpPWpGaD
Oxybutynin—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000802	0.00364	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0008	0.00364	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000793	0.0036	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000787	0.00357	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000784	0.00356	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000776	0.00353	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000756	0.00344	CbGpPWpGaD
Oxybutynin—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000746	0.00339	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000729	0.00331	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000727	0.0033	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00072	0.00327	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000706	0.00321	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000664	0.00301	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000662	0.00301	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000655	0.00298	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.00063	0.00286	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000628	0.00285	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000622	0.00282	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—DRD2—nicotine dependence	0.000615	0.00279	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TAS2R16—nicotine dependence	0.000612	0.00278	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000599	0.00272	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000597	0.00271	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000591	0.00269	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000572	0.0026	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.00057	0.00259	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000569	0.00258	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000567	0.00257	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000565	0.00257	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000561	0.00255	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	0.000481	0.00218	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—FGD1—nicotine dependence	0.00048	0.00218	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	0.000437	0.00198	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000433	0.00197	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.000432	0.00196	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000431	0.00196	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000429	0.00195	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000427	0.00194	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000425	0.00193	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	0.000424	0.00193	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	0.000348	0.00158	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000339	0.00154	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000338	0.00154	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000337	0.00153	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000337	0.00153	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000334	0.00152	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000334	0.00152	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000331	0.0015	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	0.000316	0.00143	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000307	0.0014	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000306	0.00139	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000303	0.00138	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—WASF2—nicotine dependence	0.000299	0.00136	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000299	0.00136	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.000298	0.00135	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000295	0.00134	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—WASF1—nicotine dependence	0.000286	0.0013	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000278	0.00126	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	0.000258	0.00117	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000245	0.00111	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.000244	0.00111	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000242	0.0011	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000241	0.00109	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000222	0.00101	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000222	0.00101	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000219	0.000996	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.00021	0.000955	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.00021	0.000952	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000208	0.000943	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000202	0.000916	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.000201	0.000913	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000199	0.000904	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000198	0.000899	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DRD2—nicotine dependence	0.000186	0.000847	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000182	0.000825	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.000181	0.000822	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000179	0.000814	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.000131	0.000596	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000131	0.000594	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.00013	0.000589	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000129	0.000588	CbGpPWpGaD
